Public PREFER deliverables
Patient preference studies can give valuable information to support decision making for regulators and HTA bodies. We have spent the last 5 years establishing recommendations to support development of guidelines for industry, Regulatory Authorities and HTA bodies on how and when to include patient perspectives on benefits and risks of medicinal products.
PATIENT PREFERENCE METHODOLOGY
Identification of educational and psychological feature methods
Characterising and appraising the methods
Report on methods for measuring patient benefit-risk preferences in medical treatment
DESIGNING AND CONDUCTING CLINICAL CASE STUDIES
Translate the preliminary research questions identified in WP2 to concrete study design